GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XSWX:ABT) » Definitions » Payments of Debt

Abbott Laboratories (XSWX:ABT) Payments of Debt : CHF-2,304 Mil (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Abbott Laboratories Payments of Debt?

Abbott Laboratories's Payments of Debt for the three months ended in Dec. 2023 was CHF-909 Mil.

Abbott Laboratories's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-2,304 Mil.


Abbott Laboratories Payments of Debt Historical Data

The historical data trend for Abbott Laboratories's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Payments of Debt Chart

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,381.13 -1,184.24 -232.09 -701.50 -2,160.27

Abbott Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -38.87 -1.80 -1,354.80 -908.91 -

Abbott Laboratories Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-2,304 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories Payments of Debt Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (XSWX:ABT) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories (XSWX:ABT) Headlines